TECREGEN
LIVE

Serial Number

79435837

Owner

TECregen AG

Attorney

James R Menker

Filing Date

Aug 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TECREGEN Trademark

Serial Number: 79435837

TECREGEN is a trademark filed by TECregen AG on August 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

TECregen AG (2 trademarks)

Hochbergerstrasse 60C

Entity Type: 98

Trademark Details

Filing Date

August 8, 2025

Registration Date

Not Registered

Published for Opposition

August 11, 2026

Goods & Services

Medical services; personalized medical diagnostic services based on nanobody technology; medical testing for the diagnosis and treatment of persons.

Pharmaceutical products for the treatment of immune deficiency by promoting thymic regeneration, medical and veterinary preparations for the treatment of immune deficiency by promoting thymic regeneration; hygiene preparations for medical use, namely, disinfectants; pharmaceutical substances and preparations, in particular nanobodies being antibodies for medical purposes; antibodies for medical purposes, namely, therapeutic antibody fragments for the treatment of autoimmune diseases; antibodies for medical purposes, namely, nanobodies used as medicinal preparations for the treatment of autoimmune and cancerous diseases; chemical and biochemical preparations for medical use, namely, for the treatment of immune deficiency by promoting thymic regeneration; antibodies for medical purposes, namely, nanobodies used as chemical preparations for medical use; thymus-regenerating biotechnological preparations for medical use; diagnostic preparations for medical use; antibodies for medical purposes, namely, nanobodies used as diagnostic preparations for medical use; thymus-regenerating medicines; medicines containing nanobodies for the treatment of immune deficiency by promoting thymic regeneration.

Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, infusion and injection devices for administering biological preparations; medical instruments for administering nanobody-based agents.

Scientific and technological services, namely, research and design services in the field of biotechnology, regenerative medicine and thymus regeneration; industrial analysis of pharmaceutical and biotechnological preparations, industrial research in the field of biotechnology and regenerative medicine, and industrial design services; design, development and programming of computer software; scientific research and medical research and development of biopharmaceutical preparations for thymus regeneration and immune system restoration; research and development in the field of nanobody technology; consultancy in the field of nanobody technology research and biotechnological research; development and technical maintenance of genetic banks of antibody fragments; database design and development; Software as a Service (SaaS) services featuring software for biomedical research data; computer Platform as a Service (PaaS) services featuring computer platforms for biomedical research data; web hosting of computer databases.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2026 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 9, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 9, 2026 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 26, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 22, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 22, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 2, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 30, 2025 REPR